Double Antiplatelet Therapy After Drug-Eluting Stent Implantation: Risk Associated With Discontinuation Within the First Year

Study Questions:

What is the time-dependent cardiovascular risk associated with discontinuation of double antiplatelet therapy (DAT) within the first year of implantation of a drug-eluting stent (DES)?